Evidence-based Pediatric Obstructive Sleep Apnea Detection
Launched by INDIANA UNIVERSITY · Jun 8, 2023
Trial Information
Current as of April 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Many children with obstructive sleep apnea (OSA) are not identified and thus do not receive treatment. In a previous study, the investigators found that a clinical decision support system helped primary care providers (PCPs) identify children with obstructive sleep apnea (OSA). In this system, parents of children report on possible OSA symptoms (e.g., snoring, sleepiness) in their child before the visit. If the child has OSA symptoms, the PCP receives an alert during the visit recommending further evaluation and a possible referral for a sleep study or to see a specialist. While this system...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Child ages 2.0-13.9 years at the time of OSA screening.
- • Child is a primary care patient at Eskenazi Health
- • Parent completed pre-visit questionnaire with OSA screening items
- • Child screened positive for OSA (snoring \>= 3 nights/wk + 1 additional symptom)
- Exclusion Criteria:
- • Prior OSA diagnosis
- • Prior OSA referral (ENT, PSG, Sleep medicine) in the past two years
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported